AstraZeneca will handle marketing of cholesterol-lowering drug alone
Article Abstract:
AstraZeneca PLC intends to launch Crestor, its cholesterol-lowering drug, without a marketing partner. The company also posted a 2% decrease in pretax profit for the second quarter.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Glaxo says drug may help fight prostate cancer
Article Abstract:
GlaxoSmithKline PLC hopes that its Avodart drug will become a treatment for prostate cancer. The drug is currently utilized to treat enlarged prostates.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
AstraZeneca loses Losec fight
Article Abstract:
A European Court of Justice ruling will make it easier for generic rivals of AstraZeneca PLC to sell older versions of its Losec drug. The drug is designed to treat heartburn.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Indonesian tech firms find necessity is the mother of better online access. Users world-wide are getting the message with simple SMS
- Abstracts: Telecom Italia approaches sale of stake in Retevison parent. BP takes control of Veba Oil, boosting presence in Germany
- Abstracts: Ford predicts $900 million loss on bad loans, marketing costs. Ford board considers management shake-up
- Abstracts: EU auto industry faces overhaul as Japanese gain in market share. China slaps new restrictions on Japanese auto imports
- Abstracts: Campbell's net declines by 12% on higher marketing expenses. Heinz posts a loss of $170.5 million on one-time items